Defects in optineurin- and myosin VI-mediated cellular trafficking in amyotrophic lateral sclerosis

被引:78
|
作者
Sundaramoorthy, Vinod [1 ,2 ]
Walker, Adam K. [2 ]
Tan, Vanessa [1 ]
Fifita, Jennifer A. [1 ]
Mccann, Emily P. [1 ]
Williams, Kelly L. [1 ]
Blair, Ian P. [1 ]
Guillemin, Gilles J. [1 ]
Farg, Manal A. [2 ]
Atkin, Julie D. [1 ,2 ]
机构
[1] Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, N Ryde, NSW 2109, Australia
[2] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Bundoora, Vic 3086, Australia
基金
英国医学研究理事会;
关键词
ENDOPLASMIC-RETICULUM STRESS; PROTEIN-DISULFIDE-ISOMERASE; CORD MOTOR-NEURONS; MOUSE MODEL; GOLGI-APPARATUS; AUTOPHAGOSOME MATURATION; MUTATIONS; FRAGMENTATION; PATHOLOGY; RECEPTOR;
D O I
10.1093/hmg/ddv126
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder primarily affecting motor neurons. Mutations in optineurin cause a small proportion of familial ALS cases, and wild-type (WT) optineurin is misfolded and forms inclusions in sporadic ALS patient motor neurons. However, it is unknown how optineurin mutation or misfolding leads to ALS. Optineurin acts an adaptor protein connecting the molecular motor myosin VI to secretory vesicles and autophagosomes. Here, we demonstrate that ALS-linked mutations p.Q398X and p.E478G disrupt the association of optineurin with myosin VI, leading to an abnormal diffuse cytoplasmic distribution, inhibition of secretory protein trafficking, endoplasmic reticulum (ER) stress and Golgi fragmentation in motor neuron-like NSC-34 cells. We also provide further insight into the role of optineurin as an autophagy receptor. WT optineurin associated with lysosomes and promoted autophagosome fusion to lysosomes in neuronal cells, implying that it mediates trafficking of lysosomes during autophagy in association with myosin VI. However, either expression of ALS mutant optineurin or small interfering RNA-mediated knockdown of endogenous optineurin blocked lysosome fusion to autophagosomes, resulting in autophagosome accumulation. Together these results indicate that ALS-linked mutations in optineurin disrupt myosin VI-mediated intracellular trafficking processes. In addition, in control human patient tissues, optineurin displayed its normal vesicular localization, but in sporadic ALS patient tissues, vesicles were present in a significantly decreased proportion of motor neurons. Optineurin binding to myosin VI was also decreased in tissue lysates from sporadic ALS spinal cords. This study therefore links several previously described pathological mechanisms in ALS, including defects in autophagy, fragmentation of the Golgi and induction of ER stress, to disruption of optineurin function. These findings also indicate that optineurin-myosin VI dysfunction is a common feature of both sporadic and familial ALS.
引用
收藏
页码:3830 / 3846
页数:17
相关论文
共 50 条
  • [1] Defects in optineurin- and myosin VI-mediated cellular trafficking in amyotrophic lateral sclerosis (vol 24, pg 3830, 2015)
    Sundaramoorthy, Vinod
    Walker, Adam K.
    Tan, Vanessa
    Fifita, Jennifer A.
    Mccann, Emily P.
    Williams, Kelly L.
    Blair, Ian P.
    Guillemin, Gilles J.
    Farg, Manal A.
    Atkin, Julie D.
    HUMAN MOLECULAR GENETICS, 2017, 26 (17) : 3452 - 3452
  • [2] Optineurin and amyotrophic lateral sclerosis
    Maruyama, Hirofumi
    Kawakami, Hideshi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2013, 13 (03) : 528 - 532
  • [3] Mutations of optineurin in amyotrophic lateral sclerosis
    Hirofumi Maruyama
    Hiroyuki Morino
    Hidefumi Ito
    Yuishin Izumi
    Hidemasa Kato
    Yasuhito Watanabe
    Yoshimi Kinoshita
    Masaki Kamada
    Hiroyuki Nodera
    Hidenori Suzuki
    Osamu Komure
    Shinya Matsuura
    Keitaro Kobatake
    Nobutoshi Morimoto
    Koji Abe
    Naoki Suzuki
    Masashi Aoki
    Akihiro Kawata
    Takeshi Hirai
    Takeo Kato
    Kazumasa Ogasawara
    Asao Hirano
    Toru Takumi
    Hirofumi Kusaka
    Koichi Hagiwara
    Ryuji Kaji
    Hideshi Kawakami
    Nature, 2010, 465 : 223 - 226
  • [4] Mutations of optineurin in amyotrophic lateral sclerosis
    Maruyama, Hirofumi
    Morino, Hiroyuki
    Ito, Hidefumi
    Izumi, Yuishin
    Kato, Hidemasa
    Watanabe, Yasuhito
    Kinoshita, Yoshimi
    Kamada, Masaki
    Nodera, Hiroyuki
    Suzuki, Hidenori
    Komure, Osamu
    Matsuura, Shinya
    Kobatake, Keitaro
    Morimoto, Nobutoshi
    Abe, Koji
    Suzuki, Naoki
    Aoki, Masashi
    Kawata, Akihiro
    Hirai, Takeshi
    Kato, Takeo
    Ogasawara, Kazumasa
    Hirano, Asao
    Takumi, Toru
    Kusaka, Hirofumi
    Hagiwara, Koichi
    Kaji, Ryuji
    Kawakami, Hideshi
    NATURE, 2010, 465 (7295) : 223 - U109
  • [5] Optineurin mutations in Japanese amyotrophic lateral sclerosis
    Murphy, Sinead M.
    Khan, Usman
    Alifrangis, Constantine
    Hazell, Steven
    Hrouda, David
    Blake, Julian
    Ball, Joanna
    Gabriel, Carolyn
    Markarian, Pierre
    Rees, Jeremy
    Karim, Abid
    Seckl, Michael J.
    Lunn, Michael P.
    Reilly, Mary M.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (02): : 233 - 235
  • [6] Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma
    Toth, Reka P.
    Atkin, Julie D.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [7] Rab-dependent cellular trafficking and amyotrophic lateral sclerosis
    Parakh, S.
    Perri, E. R.
    Jagaraj, C. J.
    Ragagnin, A. M. G.
    Atkin, J. D.
    CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2018, 53 (06) : 623 - 651
  • [8] Optineurin mutations in patients with sporadic amyotrophic lateral sclerosis in China
    Li, Chengyu
    Ji, Ying
    Tang, Lu
    Zhang, Nan
    He, Ji
    Ye, Shan
    Liu, Xiaolu
    Fan, Dongsheng
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2015, 16 (7-8) : 485 - 489
  • [9] Mutation analysis of the optineurin gene in familial amyotrophic lateral sclerosis
    Solski, Jennifer A.
    Williams, Kelly L.
    Yang, Shu
    Nicholson, Garth A.
    Blair, Ian P.
    NEUROBIOLOGY OF AGING, 2012, 33 (01)
  • [10] Novel optineurin mutations in sporadic amyotrophic lateral sclerosis patients
    van Blitterswijk, Marka
    van Vught, Paul W. J.
    van Es, Michael A.
    Schelhaas, Helenius J.
    van der Kooi, Anneke J.
    de Visser, Marianne
    Veldink, Jan H.
    van den Berg, Leonard H.
    NEUROBIOLOGY OF AGING, 2012, 33 (05)